Monkeypox as an emerging infectious disease: the ophthalmic implications.
conjunctiva
cornea
epidemiology
infection
microbiology
Journal
The British journal of ophthalmology
ISSN: 1468-2079
Titre abrégé: Br J Ophthalmol
Pays: England
ID NLM: 0421041
Informations de publication
Date de publication:
12 2022
12 2022
Historique:
received:
19
07
2022
accepted:
29
09
2022
pubmed:
11
10
2022
medline:
25
11
2022
entrez:
10
10
2022
Statut:
ppublish
Résumé
The 2022 outbreak of monkeypox is of worldwide significance. There has been a rapid escalation in case numbers despite efforts to contain it and the WHO has declared it a Public Health Emergency of International Concern. To date, over 51 257 laboratory-confirmed cases have been reported, the majority in non-endemic countries, with 3279 in the UK. It is vital for ophthalmologists to understand this disease and the risk it poses. Human monkeypox is a zoonotic disease caused by the monkeypox virus, a double-stranded DNA virus in the
Identifiants
pubmed: 36216412
pii: bjo-2022-322268
doi: 10.1136/bjo-2022-322268
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1629-1634Informations de copyright
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.